In the Field Sample Clauses

In the Field uniQure shall have the first right, but not the obligation, to initiate a lawsuit or take other reasonable action to enforce the Joint Patent Rights against any infringement in the Field. 4DMT shall cooperate in the prosecution of any such suit as may be reasonably requested by uniQure, including joining any action as party-plaintiff at uniQure’s sole discretion; provided that uniQure shall promptly reimburse all out-of-pocket expenses (including reasonable counsel fees and expenses) actually incurred by 4DMT in connection with such cooperation.
Search the Best Contracts

Draft contracts faster by searching through millions of contracts from the best law firms across all industries.

30+ Reviews on G2 Crowd
nixon-peabody.svg
casio.svg
baker-mckenzie.svg
p-morgan.svg
stanford-university.svg
klgates-logo.svg
harvard-university.svg
dentons.svg
In the Field. During the Program Term, Symyx shall not conduct any research activities outside the Research Program, on its own behalf or on behalf of any Third Party, directed to*, for the purpose of making Products within the scope of the Field applicable at that time, provided that Symyx shall not be precluded from conducting any research activities outside the Research Program, on its own behalf or on behalf of any Third Party, directed to*. In addition, during the Program Term, Symyx shall not knowingly provide Library Compounds for screening in a particular Field to a Third Party for use in * for the purpose of making Products within the scope of such particular Field. Symyx shall be permitted to engage in optimization projects on its own behalf or on behalf of a Third Party, within the Field applicable at that time, provided that work for or on behalf of the Third Party shall be limited to*.
In the Field. During the period beginning on the Effective Date and ending on the earlier of (A) [**] or (B) the expiration or termination of this Agreement, except pursuant to the terms of this Agreement, neither JBI nor any of its Affiliates shall directly or indirectly Develop, Manufacture or Commercialize in the Field, nor collaborate with, license, enable or otherwise authorize or grant any right to any Third Party to Develop, Manufacture or Commercialize in the Field, [**]. Notwithstanding the foregoing, the performance of Development activities in the Field with respect to a compound that is a [**] by JBI or its Affiliates shall not violate this Section 3.6.1 [**]. For avoidance of doubt, nothing in this Section 3.6.1 is intended to restrict or prohibit JBI or its Affiliates from Developing, Manufacturing or Commercializing any compound or product that does not fall within clauses (i)-(v) of this Section 3.6.1 for any Indication in the Field.
In the Field. During the Research Program Term, Symyx shall not conduct any research activities outside the Research Program, on its own behalf or on behalf of any Third Party, directed to the screening, discovery, and optimization of catalysts and catalyst systems, including but not limited to catalyst supports, activators and scavenging agents, for the purpose of making Olefin Polymers within the scope of the Field. In addition, during the Research Program Term, Symyx shall not knowingly provide Library Compounds to a Third Party for use in screening, discovery, and optimization of catalysts and catalyst systems (including but not limited to catalyst supports, activators and scavenging agents) for the purpose of making Olefin Polymers.
In the Field. ENDO’s Field Force shall be trained and shall commence Detailing on the later of (i) *** weeks of the Effective Date of this Agreement; or (ii) *** weeks from ENDO’s receipt of at least *** of the supplies of the Licensed Product and samples suitable for Launch as ordered by ENDO in accordance with Section 5 in order to support Launch of the Licensed Product.
In the Field. ENDO’s Field Force shall be trained and shall commence Detailing on the later of (i) nine (9) weeks of the Effective Date of this Agreement; or (ii) six (6) weeks from ENDO’s receipt of at least ninety percent (90%) of the supplies of the Licensed Product and samples suitable for Launch as ordered by ENDO in accordance with Section 5 in order to support Launch of the Licensed Product.
In the Field. Subject to the terms and conditions of this Agreement, Monsanto hereby grants to Landec a non-exclusive, royalty-free license to exploit the Monsanto Improvements within the Field in the Territory solely to make and use (but not sell) Licensed Product, provided that Landec may sell Licensed Product that exploits the Monsanto Improvements at the direction of Monsanto pursuant to Section 5.3.1(b).
In the Field. Subject to the terms and conditions of this Agreement, Organon grants to Cypress a worldwide license or sublicense, as applicable, with the right to sublicense under the terms described in Section 7.4, under the Organon Technology, the Joint Data and the Joint Patents to research, develop, make, have made, use, and import Development Candidates and Approved Products in the Field. Subject to the terms and conditions of this Agreement, Organon grants to Cypress a worldwide license or sublicense, as applicable, with the right to sublicense under the terms described in Section 7.4, under the Organon Technology, the Joint Data and the Joint Patents to sell and offer for sale Approved Products in the Field in the Shared Territory. The licenses granted under this Section shall be co exclusive between Cypress and Organon and shall be effective during the License Term; provided, however, that, subject to Section 7.5, these licenses (i) shall automatically become exclusive (even as to Organon) upon the date that Organon exercises the Organon Option and continue to be effective during the License Term, (ii) shall automatically become exclusive (even as to Organon) in the Specific Country as provided in Section 7.1(b), and (iii) shall automatically terminate upon the date that Cypress exercises the Cypress Option. The co-exclusive licenses mean that only Cypress and Organon may practice under such licenses except to the extent sublicenses are permitted under Section 7.4. The parties agree that these licenses shall not be construed to include the right to manufacture for commercial distribution, the rights for which are provided in Section 9, unless Organon waives such manufacturing rights or grants such rights to Cypress under terms included in the Manufacturing Agreement. To the extent that Organon, now or in the future, shall be required to obtain consent for a sublicense from a Third Party to make this grant of rights effective, Organon shall use commercially reasonable efforts to obtain such consent.
In the Field